Ethanol induces hyperprolactinemia by increasing prolactin release and lactotrope growth in female rats

Alcoholism: Clinical and Experimental Research

Volumn 26, Issue 9, 2002, Pages 1420-1429

  De, Alok ^a   Boyadjieva, Nadka ^a   Oomizu, Souichi ^a   Sarkar, Dipak K ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Estradiol; Fischer 344 Rats; Hyperprolactinemia; Pituitary Prolactin Secreting Tumors; Primary Cultures of Lactotropes

Indexed keywords

ALCOHOL; DNA; ESTRADIOL; PROLACTIN;

ALCOHOLISM; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; HISTOLOGY; HYPERPROLACTINEMIA; HYPOPHYSIS TUMOR; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; PROLACTIN SECRETING CELL; PROLACTINOMA; PROTEIN CONTENT; RAT; TUMOR DIAGNOSIS;

ANIMALS; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; FEMALE; HYPERPROLACTINEMIA; OVARIECTOMY; PITUITARY GLAND, ANTERIOR; PROLACTIN; RATS; RATS, INBRED F344;

ANIMALIA;

EID: 0036736652     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000374-200209000-00016     Document Type: Article

References (58)

1. Arrick BA, Korc M, Derynck R (1990) Differential regulation of expression of three transforming growth factor β species in human breast cancer cell lines by estradiol. Cancer Res 50:299-303.
2. Banerjee SK, De A, Sarkar DK (1994) Colocalization of prolactin and proliferating cell nuclear antigen in the anterior pituitary during estrogen-induced pituitary tumors. Cancer Lett 87:139-144.
3. Barrett JC (1987) A multistep model for neoplastic development: role of genetic and epigenetic changes, in Mechanisms of Environmental Carcinogenesis: Multistep Models of Carcinogenesis, vol 2 (Barrett CJ ed), pp 117-126. CRC Press, Boca Raton, FL.
4. Barrett JC (1991) Relationship between mutagenesis and carcinogenesis, in Origins of Human Cancer: A Comprehensive Review (Brugge J, Current T, Harlow ED, McCormick F eds), pp 101-112. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
5. Barrett JC, Huff J (1991) Cellular and molecular mechanisms of chemically induced renal carcinogenesis. Ren Fail 13:211-225.
6. Bigsby RM, Li A, Everett L (1993) Stromal-epithelial interactions regulating cell proliferation in the uterus, in Local Systems in Reproduction (Magness RR, Naftolin F eds), pp 171-188. Raven Press, New York.
7. Burns G, Sarkar DK (1993) Transforming growth factor β1-like immunoreactivity in the pituitary gland of the rat: effect of estrogen. Endocrinology 133:1444-1449.
8. Clifton KH, Furth J (1961) Changes in hormone sensitivity of pituitary mammotropes during progression from normal to autonomous. Cancer Res 21:913-920.
9. De A, Boyadjieva N, Pastorcic M, Sarkar DK (1995) Potentiation of estrogen's mitogenic effect on the pituitary gland by alcohol consumption. Int J Oncol 7:643-648.
10. El Etreby MF (1980) The role of contraceptive steroids in pathogenesis of tumors in various experimental animals and in man, in Pituitary Microadenomas (Faglia G, Giovanelli MA, MacLeod RM eds), pp 211-222. Academic Press, New York.
11. Furth J (1969) Pituitary cybernetics and neoplasia. Harvey Lect 63:47-71.
12. Gavaler JS (1994) Aging and alcohol: the hormonal status of postmenopausal women, in Reproductive Neuroendocrinology of Aging and Drug Abuse (Sarkar DK, Barnes CD eds), pp 365-378. CRC Press, Boca Raton, FL.
13. Gooren LJ, Assies J, Asscheman H, de Slegte R, van Kessel H (1988) Estrogen-induced prolactinomas in a man. J Clin Endocrinol Metab 66:444-446.
14. Gottschall PE, Sarkar DK, Meites J (1986) Persistence of low hypothalamic dopaminergic activity after removal of chronic estrogen treatment. Proc Soc Exp Biol Med 181:78-86.
15. Hardy J (1980) Ten years after the recognition of pituitary microadenomas, in Pituitary Microadenomas (Faglia G, Giovanelli MA, MacLeod RM eds), pp 211-222. Academic Press, New York.
16. Hentges S, Boyadjieva N, Sarkar DK (2000a) Transforming growth factor-β3 stimulates lactotrope cell growth by increasing basic fibroblast growth factor from folliculo-stellate cells. Endocrinology 141:859-867.
17. Hentges S, Pastorcic M, De A, Boyadjieva N, Sarkar DK (2000b) Opposing actions of two transforming growth factor-β isoforms on pituitary lactotropic cell proliferation. Endocrinology 141:1528-1535.
18. Hentges S, Sarkar DK (2001) Transforming growth factor-β regulation of estradiol-induced prolactinomas. Front Neuroendocrinol 22:340-363.
19. Ida Y, Tsujimaru S, Nakamaura K, Shirao I, Mukasa H, Egami H, Nakazawa Y (1992) Effects of acute and repeated alcohol ingestion on hypothalamic-pituitary-gonadal and hypothalamic-pituitary-adrenal functions in normal males. Drug Alcohol Depend 31:57-64.
20. Ishbashi M, Yamaji T (1985) Functional heterogeneity of human prolactin-producing pituitary adenoma cells, in Prolactin Basic and Clinical Correlates (MacLeod RM, Scapagnini U, Thorner MO eds), pp 641-702. Springer-Verlag, New York.
21. Kornet M, Goosen C, Thyssen JH, Van Ree JM (1992) Endocrine profile during acquisition of free-choice alcohol drinking in Rhesus monkeys: treatment with desglycinamide-(Arg 8)-vasopressin. Alcohol Alcohol 27:403-410.
22. Kovacs K, Horvath E, Ilse RG, Ezrin C, Ilse D (1977) Spontaneous pituitary adenomas in aging rats: a light microscopic, immunocytological and fine structural study. Beitr Pathol 161:1-16.
23. Landolt AM (1985) Variability of structure and function in prolactinomas, in Prolactin Basic and Clinical Correlates (MacLeod RM, Scapagnini U, Thorner MO eds), pp 667-681. Springer-Verlag, New York.
24. Li JJ, Gonzalez A, Banerjee S, Banerjee SK, Li SA (1993) Estrogen carcinogenesis in the hamster kidney: role of cytotoxicity and cell proliferation. Environ Health Perspect 101(Suppl 5):259-264.
25. Lloyd HM, Meares JD, Jacobi J (1975) Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells. Nature 255:497-498.
26. MacLeod RM, Scapagnini U, Thorner MO (1980) Pituitary Microadenomas. Academic Press, New York.
27. Marchesi C, De Risio C, Campanini G, Maggini C, Piazza P, Grassi M, Chiodera P, Coiro V (1992) TRH test in alcoholics: relationship of the endocrine results with neuroradiological and neuropsychological findings. Alcohol Alcohol 27:531-537.
28. Martinez F, Abril ER, Earnest DL, Watson RR (1992) Ethanol and cytokine secretion. Alcohol 9:455-458.
29. Meites J (1981) Relation of prolactin to development of spontaneous mammary and pituitary tumors, in The Prostatic Cell: Structure and Function, Part B (Murphy GP, Sandbert AA, Karr JP eds), pp 1-8. Alan R Liss, New York.
30. Mello NK, Bree MP, Mendelson JH, Ellingboe J, King NW, Sehgal P (1983) Alcohol self-administration disrupts reproductive function in female macaque monkeys. Science 221:677-679.
31. Mello NK, Mendelson JH, Bree MP, Skupny A (1988) Alcohol effects on naloxone-stimulated luteinizing hormone, follicle-stimulating hormone and prolactin plasma levels in female Rhesus monkeys. J Pharmacol Exp Ther 245:895-904.
32. Mello NK, Mendelson JH, Teoh SK (1993) An overview effects of alcohol on neuroendocrine function in women, in National Institute on Alcohol Abuse and Alcoholism, Alcohol and the Endocrine System: Research Monograph 23, No. 93-3533, pp 139-170. National Institutes of Health, Washington, DC.
33. Melnick RL (1992) Does chemically induced hepatocyte proliferation predict liver carcinogenesis? FASEB J 6:2698-2706.
34. Mendelson JH, Mello NK (1988) Chronic alcohol effects on anterior pituitary and ovarian hormones in healthy women. J Pharmacol Exp Ther 245:407-412.
35. Minami S, Sarkar DK (1997) Transforming growth factor-β1 inhibits prolactin secretion and lactotropic cell proliferation in the pituitary of oestrogen-treated Fischer 344 rats. Neurochem Int 30:499-506.
36. Moses HL, Tucker RF, Leof EB, Coffey RJ Jr, Halper J, Shipley GD (1985) Type-beta transforming growth factor is a growth stimulator and a growth inhibitor, in Cancer Cells 3 (Feramisco J, Ozanne B, Stiles C eds), pp 65-71. Cold Spring Harbor Press, New York.
37. Parrott JA, Vigne JL, Chu BZ, Skinner MK (1994) Mesenchymalepithelial interactions in the ovarian follicle involve keratinocyte and hepatocyte growth factor production by thecal cells and their action on granulosa cells. Endocrinology 135:569-575.
38. Post KD, Jackson IMD, Reichlin S (1980) The Pituitary Adenoma. Plenum Publishing, New York.
39. Purohit V (1993) Effect of alcohol on the hypothalamic pituitary-gonadal axis, in National Institute on Alcohol Abuse and Alcoholism, Alcohol and the Endocrine System: Research Monograph 23, No. 93-3533, pp 189-205.
40. National Institutes of Health, Washington, DC. Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB (1985) Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci U S A 82:119-123.
41. Russfield AB (1966) Tumors of Endocrine Glands and Secondary Sex Organs. U.S. Department of Health, Education, and Welfare, Public Health Service, Washington, DC.
42. Sanchis R, Esquifino A, Guerri C (1985) Chronic ethanol intake modifies estrous cyclicity and alters prolactin and LH levels. Pharmacol Biochem Behav 23:221-224.
43. (Meites J ed). Sarkar DK, Gottschall PE, Meites J (1983) Relation of the neuroendocrine system to development of prolactin secretion pituitary tumors, in Neuroendocrinology of Aging (Meites J ed), pp 353-376. Plenum Press, New York.
44. Sarkar DK, Hentges ST, De A, Reddy RHR (1998) Hormonal control of pituitary prolactin-secreting tumors. Front Biosci 3:934-943.
45. Sarkar DK, Kim KH, Minami S (1992) Transforming growth factor-β1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotropic growth. Mol Endocrinol 6:1825-1833.
46. Seki M, Yoshida K, Okamura Y (1991a) Hormones in amenorrheic women with alcoholics. Jpn J Fertil Steril 36:630-635.
47. Seki M, Yoshida K, Okamura Y (1991b) A study on hyperprolactinemia in female patients with alcoholics. Jpn J Alcohol Drug Depend 26:49-59.
48. Shewchuk AB, Adamson GD, Lessard P, Ezrin C (1980) The effect of pregnancy on suspected pituitary adenomas after conservative management of ovulation defects associated with galactorrhea. Am J Obstet Gynecol 136:659-666.
49. Sirbasku DA (1978) Estrogen induction of growth factors specific for hormone-responsive mammary, pituitary, and kidney tumor cells. Proc Natl Acad Sci U S A 75:3786-3790.
50. Soto AM, Sonnenschein C (1987) Cell proliferation of estrogen-sensitive cells: the case for negative control. Endocr Rev 8:44-52.
51. Soyka M, Gorig E, Naber D (1991) Serum prolactin increase induced by ethanol: a dose-dependent effect not related to stress. Psychoneuroendocrinology 16:441-446.
52. Teoh SK, Lex BW, Mendelson JH, Mello NK, Cochin J (1992) Hyperprolactinemia and macrocytosis in women with alcohol and polysubstance dependence. J Stud Alcohol 53:176-182.
53. Teoh SK, Mello NK, Mendelson JH (1994) The effect of alcohol abuse on the menstrual cycle, in Reproductive Neuroendocrinology of Aging and Drug Abuse (Sarkar DK, Barnes CD eds), pp 335-364. CRC Press, Boca Raton, FL.
54. Tiboldi T, Viraegh S, Kovacs K, Hodi M, Julesz M (1967) Electron microscopic studies of estrogen-induced adenomata developing in intersellar and transplanted rat anterior pituitaries. J Microsc 6:677.
55. Välimäki M, Pelkonen R, Harkonen M, Tuomala P, Koistinen P, Roine R, Ylikahri R (1990) Pituitary-gonadal hormones and adrenal androgens in non-cirrhotic female alcoholics after cessation of alcohol intake. Eur J Clin Invest 20:177-181.
56. Van Thiel DH (1979) Feminization of chronic alcoholic men: a formulation. Yale J Biol Med 52:219-225.
57. Venkateswaran V, Oliver SA, Ram TG, Hosick HL (1993) Salivary mesenchyme cells that induce mammary epithelial hyperplasia up-regulate EGF receptors in primary cultures of mammary epithelium within collagen gels. Growth Regul 3:138-145.
58. Ward JM, Hagiwara A, Anderson LM, Lindsey K, Diwan BA (1988) The chronic hepatic or renal toxicity of di(2-ethylhexyl)phthalate, acetaminophen, sodium barbital and pentobarbital in male B6C3F1 mice: autoradiographic, immunohistochemical and biochemical evidence for levels of DNA synthesis not associated with carcinogenesis or tumor promotion. Toxicol Appl Pharmacol 96:494-506.